Mitochondrial function is a contributing, but not necessarily essential factor to lower the levels of triglycerides in plasma, according to Carine Lindquist‘s PhD thesis.

MAIN RESULTS:

1. 1-triple TTA reduces triglyceride levels in plasma as a result of increased hepatic mitochondrial oxidation.
2. 1-triple TTA reduces triglyceride levels in plasma even when levels of L-carnitine are low.
3. 1-triple TTA probably influences triglyceride clearance and biosynthesis.

THESIS DEFENCE:

Thesis: Mitochondrial function in the regulation of plasma and liver triacylglycerols
Candidate: Carine Lindquist
Time: April 27, 2018 at 11:15
Place: Univeristy of Bergen: BB-building, Auditorium 1
Link to university website (in Norwegian)

SUMMARY:

(1) Rats fed for three weeks with 2-(tridec-12-yn-1-ylthio)acetic acid (1-triple TTA) had a five-fold increase of hepatic mitochondrial oxidation of fatty acids. Triglyceride levels in both plasma and liver decreased substantially, probably as a consequence of downregulated APOC-III and upregulated LPL and the VLDL receptor.

REFERENCES:

(1) Lindquist, C., Bjørndal, B., Rossmann, C. R., Tusubira, D., Svardal, A., Røsland, G. V., Tronstad, K. J., Hallström,, S., & Berge, R. K. (2017). Increased hepatic mitochondrial FA oxidation reduces plasma and liver TG levels and is associated with regulation of UCPs and APOC-III in rats. Journal of lipid research, 58(7), 1362-1373.

(2) Lindquist, C., Bjørndal, B., Rossmann, C. R., Svardal, A., Hallström, S., & Berge, R. K. (2018). A fatty acid analogue targeting mitochondria exerts a plasma triacylglycerol lowering effect in rats with impaired carnitine biosynthesis. PloS one, 13(3), e0194978.